Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
City of Hope Medical Center
Children's Oncology Group
Emory University
Nationwide Children's Hospital
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Augusta University
Hoffmann-La Roche